Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Cervical Cancer

Free Subscription 06.10.2025 1 ACS Appl Bio Mater 1 Adv Radiat Oncol 1 Arch Gynecol Obstet 1 Biomedicines 1 Biosens Bioelectron 4 BMC Cancer 2 BMC Health Serv Res 2 BMC Infect Dis 1 BMC Psychol 1 BMC Public Health 2 BMC Womens Health 1 Br J Cancer 4 Cancer Biol Med 1 Cancer Control 2 Cancer Med 5 Cancers (Basel) 1 Cell Death Dis 1 Cell Immunol 3 Clin Med Insights Oncol 1 Colloids Surf B Biointerfaces 1 Cureus 2 Curr Issues Mol Biol 2 Diagn Cytopathol 1 Discov Oncol 1 EJHaem 1 Eur J Pharmacol 1 Front Genet 1 Front Immunol 7 Front Oncol 1 Front Public Health 1 Genes (Basel) 1 Gynecol Oncol Rep 1 Health Promot Pract 1 Healthcare (Basel) 1 Int J Gynaecol Obstet 1 Int J Gynecol Cancer 1 Int J Gynecol Pathol 2 Int J Mol Sci 1 J Adv Res 1 J Community Health 1 J Egypt Natl Canc Inst 1 J Gynecol Oncol 1 J Health Psychol 1 J Immunother Cancer 1 J Med Chem 1 J Med Econ 1 J Med Virol 1 J Mol Diagn 1 J Pharmacokinet Pharmacodyn 1 J Rheumatol 1 JAMA 1 JAMA Netw Open 4 JCO Glob Oncol 1 Keio J Med 1 Lab Invest 1 Life Sci 1 Lupus 1 Med Sci Monit 1 Medicina (Kaunas) 2 Medicine (Baltimore) 1 Mol Pharm 1 Nanotechnology 1 Naunyn Schmiedebergs Arch Pharmacol 2 O G Open 1 Oncol Rev 1 Oncologist 1 Pathobiology 2 Pathogens 1 PeerJ 1 Pharmaceuticals (Basel) 1 Phenomics 1 Phys Med Biol 1 PLOS Glob Public Health 2 PLoS One 1 Prev Med Rep 1 Radiat Prot Dosimetry 1 Rev Gaucha Enferm 4 Sci Rep 1 Ugeskr Laeger 1 Vaccine 1 Viruses 1 World J Clin Oncol 1 Zhonghua Yi Xue Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

ACS Appl Bio Mater

1. WANG K, Sun J, Zhang H, Li L, et al
   Research on the Effect of NK Cells Based on Functionalized Magnetic Beads on Cervical Cancer Mice.
   ACS Appl Bio Mater. 2025 Oct 3. doi: 10.1021/acsabm.5c00811.
   PubMed         Abstract available
   
   

   
   Adv Radiat Oncol

2. LIU B, Bao Y, Ma J, Wang X, et al
   Clinical Efficacy of Hydrogen Therapy on Acute Radiation Enteritis and Inflammatory Response in Patients with Cervical Cancer Undergoing Concurrent Chemoradiation Therapy.
   Adv Radiat Oncol. 2025;10:101879.
   PubMed         Abstract available
   
   

   
   Arch Gynecol Obstet

3. KAPLAN C, Crane L, Collins A, Parker RL, et al
   At-home self-collection device offers an effective and preferred method to engage high BMI women in cervical cancer screening: method comparison study.
   Arch Gynecol Obstet. 2025 Oct 3. doi: 10.1007/s00404-025-08189.
   PubMed         Abstract available
   
   

   
   Biomedicines

4. YORDANOV A, Damyanova P, Vasileva-Slaveva M, Karakadieva K, et al
   Clinical Significance of Tumor Infiltrating T-Helper and Regulatory Cells in Bulgarian Cervical Cancer Patients.
   Biomedicines. 2025;13:2206.
   PubMed         Abstract available
   
   

   
   Biosens Bioelectron

5. LEE GH, Kim S, Kim SH, Lee ES, et al
   Transcription cascade reaction-driven isothermal amplification for ultrasensitive detection of high-risk human papillomavirus.
   Biosens Bioelectron. 2025;290:117984.
   PubMed         Abstract available
   
   

   
   BMC Cancer

6. SONG Y, Qin H, Huang S, Wang J, et al
   alpha-hederin inhibits cervical cancer progression by inducing DNA damage-dependent cell cycle blockade and apoptosis.
   BMC Cancer. 2025;25:1503.
   PubMed         Abstract available
   
   
7. LI X, Mao Z, Li Q, He M, et al
   Prognostic factors of locally advanced cervical cancer after concurrent chemoradiotherapy: a retrospective study.
   BMC Cancer. 2025;25:1498.
   PubMed         Abstract available
   
   
8. BRUNO MT, Cavallaro AG, Sudano MC, Fratto MC, et al
   Role of endocervical curettage in detecting CIN2 + in postmenopausal women with persistent high-risk HPV and type 3 transformation zone.
   BMC Cancer. 2025;25:1486.
   PubMed         Abstract available
   
   
9. WYATT LC, Nguyen CH, LeCroy MN, Foster V, et al
   Prevalence of breast, cervical, and colorectal cancer screenings among select New York City populations.
   BMC Cancer. 2025;25:1469.
   PubMed         Abstract available
   
   

   
   BMC Health Serv Res

10. MOUKAM AMD, Salah N, Tankeu Happi GW, Metchehe LDD, et al
    Acceptability of home-based HPV self-sampling for cervical cancer screening among users and providers in the West region of Cameroon: a cross-sectional study.
    BMC Health Serv Res. 2025;25:1303.
    PubMed         Abstract available
    
    
11. BARMON D, Nath A, Aparajita, Sharma JD, et al
    Advocacy to action for cervical cancer elimination in the state of Assam: a narrative review of the government policies and the latest report of NCDIR survey.
    BMC Health Serv Res. 2025;25:1291.
    PubMed         Abstract available
    
    

    
    BMC Infect Dis

12. FENG T, Zhang W, Zhao T, Zhou S, et al
    Comparative analysis of preoperative and postoperative HPV infection dynamics in patients with cervical intraepithelial neoplasia and cervical cancer: implications for screening and management.
    BMC Infect Dis. 2025;25:1195.
    PubMed         Abstract available
    
    
13. ZIDI S, Almawi WY, Abassi S, Khadraoui N, et al
    Genital mycoplasma infections: a hidden factor in cervical cancer progression? A systematic review and meta-analysis.
    BMC Infect Dis. 2025;25:1120.
    PubMed         Abstract available
    
    

    
    BMC Psychol

14. JIN XH, Liu XM, Huang HY
    The mediating role of medical coping modes between anxiety and fear of progression in patients with cervical intraepithelial neoplasia grade 3: a cross-sectional survey.
    BMC Psychol. 2025;13:1019.
    PubMed         Abstract available
    
    

    
    BMC Public Health

15. KUBURA D, Sampson S, Erekosima G, Dauda M, et al
    Stakeholders' perspectives on lessons learnt from HPV mass vaccination in Nigeria.
    BMC Public Health. 2025;25:3062.
    PubMed         Abstract available
    
    

    
    BMC Womens Health

16. WANG M, Xu J, Xu S, Wu Y, et al
    The primary surgery improved the survival of FIGO stage IIIC1 cervical cancer with T1b-T2a tumors.
    BMC Womens Health. 2025;25:454.
    PubMed         Abstract available
    
    
17. SALEHI AM, Shahbazi F, Garavand R, Kamkari S, et al
    Global socioeconomic inequalities in breast, cervical, ovarian, and uterine cancers incidence, mortality, disability-adjusted life year's rates: a relative concentration index analysis.
    BMC Womens Health. 2025;25:433.
    PubMed         Abstract available
    
    

    
    Br J Cancer

18. BAENA A, Picconi MA, Mendoza L, Ferrera A, et al
    Short-term repeat HPV testing for triaging HPV-positive women in cervical cancer screening.
    Br J Cancer. 2025 Oct 3. doi: 10.1038/s41416-025-03193.
    PubMed         Abstract available
    
    

    
    Cancer Biol Med

19. DONG M, Xie J, Zhao X, Zhao F, et al
    Impact of government-organized screening programs on the economic burden of cervical cancer across five disease courses: a multistage regression and mediation analysis.
    Cancer Biol Med. 2025 Sep 29:j.issn.2095-3941.2025.0418.
    PubMed         Abstract available
    
    
20. JIA X, Gao C, Da X, Shi J, et al
    Evaluation of an intelligent digital platform for population management in cervical cancer screening.
    Cancer Biol Med. 2025 Sep 29:j.issn.2095-3941.2025.0419.
    PubMed         Abstract available
    
    
21. BASU P
    Progress toward cervical cancer elimination: global disparities and China's contributions.
    Cancer Biol Med. 2025 Sep 29:j.issn.2095-3941.2025.0428.
    PubMed        
    
    
22. QIAO Y
    Eliminating cervical cancer: a global health imperative for women.
    Cancer Biol Med. 2025 Sep 26:j.issn.2095-3941.2025.0529.
    PubMed        
    
    

    
    Cancer Control

23. ASEMPAH E, Ikpebe E, Wyndham-West M, Wiktorowicz ME, et al
    Challenges and Opportunities for Cervical Cancer Prevention Through HPV Vaccination in Ghana: A Public Health Policy Analysis.
    Cancer Control. 2025;32:10732748251383280.
    PubMed         Abstract available
    
    

    
    Cancer Med

24. YAO S, Chen S, Wan S, Wang A, et al
    LAG3 as a Tumor Suppressor and Immune Regulator in Cervical Cancer: From Functional Validation to Therapeutic Strategy.
    Cancer Med. 2025;14:e71278.
    PubMed         Abstract available
    
    
25. MOSS JL, Bernacchi VE, Entenman J, Costigan H, et al
    Follow-Up After Receiving Abnormal Results From Self-Sampled Colorectal and Cervical Cancer Screening Tests Among Underserved Patients.
    Cancer Med. 2025;14:e71283.
    PubMed         Abstract available
    
    

    
    Cancers (Basel)

26. HABIB N, Idoubba S, Futcher F, Pieri E, et al
    Cervical Cancer Treatment and Fertility: What We Know and What We Do.
    Cancers (Basel). 2025;17:3057.
    PubMed         Abstract available
    
    
27. PARULEKAR M, Kim MK, Noh JJ, Suh DH, et al
    Clinicopathological Factors Affecting Prognosis in Patients with Advanced Cervical Cancer Undergoing Concurrent Chemoradiation Therapy.
    Cancers (Basel). 2025;17:3042.
    PubMed         Abstract available
    
    
28. GUITIAN M, Reina G, Carlos S
    The Role of Nutrition in HPV Infection and Cervical Cancer Development: A Review of Protective Dietary Factors.
    Cancers (Basel). 2025;17:3020.
    PubMed         Abstract available
    
    
29. RESTIVO V, Graci D, Immordino A, Mancuso DG, et al
    Cervical Cancer Screening in Refugee and Migrant Populations: Results of Systematic Review and Meta-Analysis in Cross-Sectional and Cohort Studies.
    Cancers (Basel). 2025;17:2966.
    PubMed         Abstract available
    
    
30. KOWALKOWSKA ME, Kaminska K, Wojtysiak J, Koper K, et al
    Tumor Mutational Burden in Cervical Cancer as Potential Marker for Immunotherapy Responders.
    Cancers (Basel). 2025;17:2963.
    PubMed         Abstract available
    
    

    
    Cell Death Dis

31. FENG S, Zhao M, Zhang D, Zhang Y, et al
    TUFT1 regulates cancer progression by suppressing centrosome amplification and mitotic spindle multipolarity.
    Cell Death Dis. 2025;16:673.
    PubMed         Abstract available
    
    

    
    Cell Immunol

32. GNANAGURUSAMY J, Sabanayagam R, Krishnamoorthy S, Balasubramanian V, et al
    EGCG remodels the TGF-beta cervical cancer micro-environment towards immune responsiveness.
    Cell Immunol. 2025;418:105027.
    PubMed         Abstract available
    
    

    
    Clin Med Insights Oncol

33. CHEN J, Zhang M, Gong Y, Gu Z, et al
    The Role of the Vaginal Microbiome in Immune Modulation in Cervical Cancer: Composition, Molecular Mechanisms, and Therapeutic Potential.
    Clin Med Insights Oncol. 2025;19:11795549251380470.
    PubMed         Abstract available
    
    
34. TAKAHASHI T, Kobayashi Y, Sakurai R, Matsuoka K, et al
    A Systematic Review of the Application of Artificial Intelligence in Colposcopy: Diagnostic Accuracy for Cervical Intraepithelial Neoplasia and Cervical Cancer.
    Clin Med Insights Oncol. 2025;19:11795549251374908.
    PubMed         Abstract available
    
    
35. LIU H, Zhang Z, Guo X, Wang T, et al
    The Effect of Bladder and Rectum Volume Changes on Exposed Organ Volume During Intensity-Modulated Radiotherapy for Cervical Cancer.
    Clin Med Insights Oncol. 2025;19:11795549251377910.
    PubMed         Abstract available
    
    

    
    Colloids Surf B Biointerfaces

36. QUAN C, Jiang P, Gao G, Wang Z, et al
    Mesoporous silica-coated gold nanorod grafted with cisplatin prodrug on the surface enhances radiotherapy for cervical cancer via triple-strategy approach.
    Colloids Surf B Biointerfaces. 2025;257:115160.
    PubMed         Abstract available
    
    

    
    Cureus

37. RAI H, Verma D, Meena R, Uniya U, et al
    Cervical Cancer Screening in HIV-Positive Women by Conventional Exfoliative Cytology and Liquid-Based Cytology.
    Cureus. 2025;17:e91118.
    PubMed         Abstract available
    
    

    
    Curr Issues Mol Biol

38. ZACAPALA-GOMEZ AE, Hernandez-Galicia G, Torres-Rojas FI, Banos-Hernandez CJ, et al
    Let-7c/RUNX1 Axis Promotes Cervical Cancer: A Bioinformatic Analysis.
    Curr Issues Mol Biol. 2025;47:757.
    PubMed         Abstract available
    
    
39. VARESANO S, Ciccarese G, Parente P, Paudice M, et al
    Integrating Molecular Diagnostics into Cervical Cancer Screening: A Workflow Using FFPE Tissue Samples.
    Curr Issues Mol Biol. 2025;47:679.
    PubMed         Abstract available
    
    

    
    Diagn Cytopathol

40. TANAKA K, Lami K, Odate T, Hori T, et al
    Cytology Screening Using Z-Stack Digital Slides: A Validation Study.
    Diagn Cytopathol. 2025;53:568-575.
    PubMed         Abstract available
    
    
41. ZHOU Q, Luo K, Zhao L
    A Study on the Impact of HPV Genotype Infection Patterns on the Occurrence of High-Grade Squamous Intraepithelial Lesion.
    Diagn Cytopathol. 2025;53:529-535.
    PubMed         Abstract available
    
    

    
    Discov Oncol

42. LI J, Wang Y, Pei J, Wang M, et al
    Low pre-treatment neutrophil-to-lymphocyte ratio predicted a better survival in recurrent/metastatic cervical cancer treated with PD-1/PD-L1 inhibitors.
    Discov Oncol. 2025;16:1756.
    PubMed         Abstract available
    
    

    
    EJHaem

43. 
    Correction to "Catastrophic Venous and Arterial Thrombosis in a Young Female With Cervical Cancer".
    EJHaem. 2025;6:e70149.
    PubMed         Abstract available
    
    

    
    Eur J Pharmacol

44. BAVISHI L, Butani SB, Patel SS
    Small Interfering RNA (siRNA) Based Therapies for Cancer Treatment: A Special Focus on Cervical Cancer.
    Eur J Pharmacol. 2025 Sep 26:178198. doi: 10.1016/j.ejphar.2025.178198.
    PubMed         Abstract available
    
    

    
    Front Genet

45. CHEN W, Liu C, Li S, Xie X, et al
    ZC3H18 regulates alternative splicing and related genes in cervical cancer.
    Front Genet. 2025;16:1621238.
    PubMed         Abstract available
    
    

    
    Front Immunol

46. SU Q, Tian X, Li F, Yu X, et al
    Integrated multi-omics analysis of single-cell and spatial transcriptomics reveals distinct hpv-associated immune microenvironment features and prognostic signatures in cervical cancer.
    Front Immunol. 2025;16:1612623.
    PubMed         Abstract available
    
    

    
    Front Oncol

47. ZHANG N
    Early detection and management strategies for isolated splenic metastasis in cervical cancer: a case report.
    Front Oncol. 2025;15:1639109.
    PubMed         Abstract available
    
    
48. LIU Y, Zhang X, Xin W, Ding Y, et al
    A long-term retrospective analysis of oncologic and fertility outcomes in cervical cancer patients undergoing radical trachelectomy.
    Front Oncol. 2025;15:1591923.
    PubMed         Abstract available
    
    
49. LI B, Chen L, Sun C, Wang J, et al
    Leveraging deep learning for early detection of cervical cancer and dysplasia in China using U-NET++ and RepVGG networks.
    Front Oncol. 2025;15:1624111.
    PubMed         Abstract available
    
    
50. SHI P, Zhang W, Yao Q, Yuan Z, et al
    Correction: CS Ratio is an immune-related prognostic biomarker for cervical cancer.
    Front Oncol. 2025;15:1697346.
    PubMed         Abstract available
    
    
51. ZHANG L, Zhang Q, Pang B, Tan Z, et al
    Epidemiological characteristics and risk factors of high-risk HPV infection, cervical cancer, and precancerous lesions among women in Southwestern China.
    Front Oncol. 2025;15:1645748.
    PubMed         Abstract available
    
    
52. LI W, Wang X, Wu M, Tan X, et al
    Quality of life in cervical cancer survivors after nerve-sparing radical hysterectomy, conventional radical hysterectomy or concurrent chemoradiotherapy.
    Front Oncol. 2025;15:1654730.
    PubMed         Abstract available
    
    
53. VASIC J, Prvulovic Bunovic N, Saroskovic M, Vukovic J, et al
    The apparent diffusion coefficient as a biomarker in the diagnosis of cervical cancer and the assessment of therapeutic response to chemoradiation therapy.
    Front Oncol. 2025;15:1610090.
    PubMed         Abstract available
    
    

    
    Front Public Health

54. MA Y, Lai X, Fang H
    Global, regional, and national disease burden and economic costs of cervical cancer (1991-2021): a multidimensional data synthesis analysis.
    Front Public Health. 2025;13:1633975.
    PubMed         Abstract available
    
    

    
    Genes (Basel)

55. MARTINS TR, Levi JE
    Molecular Screening for Cervical Cancer.
    Genes (Basel). 2025;16:1041.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol Rep

56. THAKER PH, Lu H, Zhang YJ, Trapali M, et al
    Treatment preferences of patients with recurrent or metastatic cervical cancer: a discrete choice experiment in the US.
    Gynecol Oncol Rep. 2025;61:101947.
    PubMed         Abstract available
    
    

    
    Health Promot Pract

57. RIVERO-MENDOZA D, Gjoka K, Singh L, Adkins L, et al
    Health System Strategies to Improve the Uptake of Cervical Cancer Screening in Sub-Saharan Africa: A Scoping Systematic Review.
    Health Promot Pract. 2025 Oct 3:15248399251370668.
    PubMed         Abstract available
    
    

    
    Healthcare (Basel)

58. NCANE Z, Gonah L, Estrada GAP, Faleni M, et al
    Knowledge, Attitudes, and Practices of Healthcare Workers on Cervical Cancer Screening in Rural Healthcare Facilities of the Eastern Cape.
    Healthcare (Basel). 2025;13:2316.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

59. SINGLA A, Mehta S, Grover A, Mishra AK, et al
    Cervical cancer screening: Is self-sampling the answer?
    Int J Gynaecol Obstet. 2025 Sep 30. doi: 10.1002/ijgo.70562.
    PubMed         Abstract available
    
    

    
    Int J Gynecol Cancer

60. MURAD V, Chawla T, Brien CO
    The missing link in SHAPE: standardizing magnetic resonance imaging assessment of stromal invasion for cervical cancer.
    Int J Gynecol Cancer. 2025;35:102133.
    PubMed        
    
    

    
    Int J Gynecol Pathol

61. STOLNICU S, Talia KL, Banet N, McCluggage WG, et al
    Lymphovascular Space Invasion in Cervical Cancer: A Review of Clinical Significance and Pathologic Issues.
    Int J Gynecol Pathol. 2025 Sep 3. doi: 10.1097/PGP.0000000000001135.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

62. LI J, Li S
    From Viral Infection to Genome Reshaping: The Triggering Role of HPV Integration in Cervical Cancer.
    Int J Mol Sci. 2025;26:9214.
    PubMed         Abstract available
    
    
63. LEE KJ, Kim G, Seo B, Jeong SY, et al
    A Tissue Factor Bi-Specific T-Cell Engager Provides Effective Targeting and Cytotoxicity Against Cervical Cancer Cell Lines.
    Int J Mol Sci. 2025;26:8941.
    PubMed         Abstract available
    
    

    
    J Adv Res

64. HUANG Y, Lin W, Chen X, Zheng X, et al
    Analyzing and forecasting global cervical cancer burden based on WHO's elimination strategy: insights and projections from a 1990-2021 global burden of disease (GBD) study covering 204 countries and territories.
    J Adv Res. 2025 Sep 25:S2090-1232(25)00742-8. doi: 10.1016/j.jare.2025.
    PubMed         Abstract available
    
    

    
    J Community Health

65. SMITH DG, Dantes EM, Beyl R, de Koter YXA, et al
    Perceived Risk and HPV Vaccination Awareness Among Women in Rural and Underserved Communities in the State of Louisiana.
    J Community Health. 2025;50:826-832.
    PubMed         Abstract available
    
    

    
    J Egypt Natl Canc Inst

66. GUPTA RD, Saha S, Rahman MA, Addo PNO, et al
    Factors influencing breast and cervical cancer screening among ever-married women aged 15-49 in Jordan: an analysis of the 2023 Jordan population and family health survey.
    J Egypt Natl Canc Inst. 2025;37:65.
    PubMed         Abstract available
    
    

    
    J Gynecol Oncol

67. MABUCHI S, Komura N, Nakamura H, Maeda M, et al
    The activity of immune checkpoint inhibitors in patients with recurrent cervical cancer developed in previously irradiated field: clinical and immunohistochemical investigations.
    J Gynecol Oncol. 2025 Sep 15. doi: 10.3802/jgo.2026.
    PubMed         Abstract available
    
    

    
    J Health Psychol

68. ASLAN B, Onal O
    Factors influencing the decision to undergo cervical cancer screening tests (Pap Smear and HPV-DNA testing) in women aged 30-65: The role of HPV knowledge, cancer screening perception, health anxiety, and behaviors for protection against sexually tran
    J Health Psychol. 2025 Oct 3:13591053251376855. doi: 10.1177/13591053251376855.
    PubMed         Abstract available
    
    

    
    J Immunother Cancer

69. SYDING LA, Plackova K, Pavelkova L, Aquino-Perez C, et al
    High Treg and PMN-MDSC densities are a hallmark of tertiary lymphoid structures in fatal cases of cervical cancer.
    J Immunother Cancer. 2025;13:e012613.
    PubMed         Abstract available
    
    

    
    J Med Chem

70. SUN W, Angelova A, Han X, Wang X, et al
    Self-Assembling Amphiphilic Peptides Target the VDAC1-Hexokinase-II Complex to Induce Apoptosis in Cervical Carcinoma Cells.
    J Med Chem. 2025;68:18857-18868.
    PubMed         Abstract available
    
    

    
    J Med Econ

71. WIJENAYAKE N, Ladino D, Patterson K, Rosim M, et al
    Evaluating the broad societal value of pembrolizumab in women's cancer in Brazil.
    J Med Econ. 2025;28:1651-1668.
    PubMed         Abstract available
    
    

    
    J Med Virol

72. CHEN S, Li T, Wang Y, Dai Y, et al
    The Impact of Specific Sexually Transmitted Pathogens on Cervix: A Prospective Study Based on Cervical Cancer Screening Cohort.
    J Med Virol. 2025;97:e70616.
    PubMed         Abstract available
    
    

    
    J Mol Diagn

73. TAL S, Vowels JA, Gonzalez D, Polychronopoulou E, et al
    Performance Evaluation of the Aptima hrHPV Nucleic Acid Amplification and Papanicolaou Co-Testing in Cervical Cancer Screening: Insights from a Diverse Population-Based Retrospective Study.
    J Mol Diagn. 2025 Sep 23:S1525-1578(25)00218.
    PubMed         Abstract available
    
    

    
    J Pharmacokinet Pharmacodyn

74. FENG S, Gunawan R, Passey C, Voellinger J, et al
    Exposure-safety Markov modeling of ocular adverse events in patient populations treated with tisotumab vedotin.
    J Pharmacokinet Pharmacodyn. 2025;52:55.
    PubMed         Abstract available
    
    

    
    J Rheumatol

75. BROOKS RT, Hulshizer CA, Hanson AC, Davis JM 3rd, et al
    Cumulative Incidence of Cancer Screening for Breast, Cervical, Prostate, and Colorectal Cancer in Patients with Rheumatoid Arthritis.
    J Rheumatol. 2025 Jul 25:jrheum.2025-0190. doi: 10.3899/jrheum.2025-0190.
    PubMed         Abstract available
    
    

    
    JAMA

76. ANDERER S
    Anal Cancer Risk Rises With Age and Time Among Cervical Cancer Survivors.
    JAMA. 2025 Sep 26. doi: 10.1001/jama.2025.13888.
    PubMed        
    
    

    
    JAMA Netw Open

77. MEENAN RT, Lacey C, Buist DSM, Tiro JA, et al
    Cost-Effectiveness of HPV Self-Testing Options for Cervical Cancer Screening.
    JAMA Netw Open. 2025;8:e2534960.
    PubMed         Abstract available
    
    

    
    JCO Glob Oncol

78. JAYAKUMAR B, Ngua Roca A, Teklemichael L, Ondo Oyono M, et al
    Lessons Learned From 7 Years of Implementing Cervical Cancer Screening and Treatment in Equatorial Guinea.
    JCO Glob Oncol. 2025;11:e2400658.
    PubMed         Abstract available
    
    
79. NGUYEN VT, Arockiam S, Kumar P, Eger J, et al
    Diagnostic Translational Considerations for Global Health Settings: Portable Detection of Human Papillomavirus for Cervical Cancer Screening in India.
    JCO Glob Oncol. 2025;11:e2500117.
    PubMed         Abstract available
    
    
80. SOLER M, Alfaro K, Rauda JC, Torres E, et al
    Adoption and Implementation of Affordable Cancer Technologies in El Salvador: Identifying Implementation Strategies for Successful Cervical Cancer Prevention in Resource-Limited Settings.
    JCO Glob Oncol. 2025;11:e2500065.
    PubMed         Abstract available
    
    
81. AZIM MR, Wong EYT, Rahman MM, Islam MS, et al
    Knowledge, Attitudes, and Health-Seeking Behavior for Cervical, Breast, and Oral Cancers Among Women in Jashore, Bangladesh: A Cross-Sectional Study.
    JCO Glob Oncol. 2025;11:e2500304.
    PubMed         Abstract available
    
    

    
    Keio J Med

82. NAKAMURA K, Masuda K, Seki T, Kitago M, et al
    Potential New Tumors Associated with Hereditary Breast and Ovarian Cancer (HBOC).
    Keio J Med. 2025;74:158-161.
    PubMed         Abstract available
    
    

    
    Lab Invest

83. QIAN H, Tang M, Wu T, Sun Z, et al
    The Role of Replication Stress-Related Genes in Cervical Cancer Radiotherapy Resistance: A Bioinformatic and Experimental Validation.
    Lab Invest. 2025 Sep 22:104244. doi: 10.1016/j.labinv.2025.104244.
    PubMed         Abstract available
    
    

    
    Life Sci

84. CHEN Q, Wang H, Zhang H, Zhu Z, et al
    EdgeNeXt-SEDP for cervical adenocarcinoma HPV-associated and non-HPV-associated diagnosis and decision support.
    Life Sci. 2025;380:123931.
    PubMed         Abstract available
    
    

    
    Lupus

85. LEE J, Lim H, Baek IW, Chung MK, et al
    Cervical cancer screening rates in Korean women of childbearing age with systemic lupus erythematosus.
    Lupus. 2025 Oct 3:9612033251386086. doi: 10.1177/09612033251386086.
    PubMed         Abstract available
    
    

    
    Med Sci Monit

86. SUTRISNO S, Marlina D, Dewi Poernomo MAP, Utomo A, et al
    Elevated Body Mass Index as a Predictor of Cervical Cancer and Precancerous Lesions.
    Med Sci Monit. 2025;31:e947820.
    PubMed         Abstract available
    
    

    
    Medicina (Kaunas)

87. YORDANOV A, Tsoneva E, Hasan I, Kostov S, et al
    Sentinel Lymph Node Dissection-Novelty, Trend, or a Paradigm Shift in Surgical Decision-Making for Early Cervical Cancer?
    Medicina (Kaunas). 2025;61:1660.
    PubMed         Abstract available
    
    

    
    Medicine (Baltimore)

88. BAN R, Zeng J, Hao J
    Dosimetric study on the effect of minimum distance between optimization structures and planning target volume on small intestine dose in cervical cancer VMAT plans.
    Medicine (Baltimore). 2025;104:e44715.
    PubMed         Abstract available
    
    
89. YAN Y, Zhang L, Yuan S, Zhang T, et al
    Association between the oxidative balance score and gynecologic cancers from the National Health and Nutrition Examination Survey: An observational study.
    Medicine (Baltimore). 2025;104:e44782.
    PubMed         Abstract available
    
    

    
    Mol Pharm

90. LIU C, Ding L, Chen S, Liu L, et al
    Enhancing Sonodynamic Therapy for Cervical Cancer Using Ultrasound-Activated BTO@PEG.
    Mol Pharm. 2025 Sep 30. doi: 10.1021/acs.molpharmaceut.5c00765.
    PubMed         Abstract available
    
    

    
    Nanotechnology

91. LE THI P, Nguyen HT, Quoc Nguyen V, Tran Nguyen H, et al
    Enhanced Cytotoxicity of Cisplatin-Loaded Brij S100-Alginate-Taurine Nanogels Against HeLa Cervical Cancer Cells.
    Nanotechnology. 2025 Sep 29. doi: 10.1088/1361-6528.
    PubMed         Abstract available
    
    

    
    Naunyn Schmiedebergs Arch Pharmacol

92. HU S, Lu Y, Pandey P, Mujtaba MA, et al
    Oroxylin A exerts antiproliferative effects through downregulation of E6 and E7 oncogenes in cervical cancer HeLa cells.
    Naunyn Schmiedebergs Arch Pharmacol. 2025 Oct 1. doi: 10.1007/s00210-025-04601.
    PubMed         Abstract available
    
    

    
    O G Open

93. SANTIAGO-RODRIGUEZ EJ, Ramos TS, Ramos-Cartagena JM, Torres-Cintron CR, et al
    Effects of Hurricanes and the Coronavirus Disease 2019 (COVID-19) Pandemic on Cervical Cancer Diagnosis in Puerto Rico.
    O G Open. 2024;1:36.
    PubMed         Abstract available
    
    
94. ALIMENA S, Lykken JM, Tiro JA, Chubak J, et al
    Accessibility of Criteria to Exit Cervical Cancer Screening at Age 65 Years in the Electronic Health Record.
    O G Open. 2024;1:32.
    PubMed         Abstract available
    
    

    
    Oncol Rev

95. MLAMBO A, Su S, Dhlamini Q, Zhang Y, et al
    Patterns of immune cell infiltration and oxidative stress in cervical cancer.
    Oncol Rev. 2025;19:1570071.
    PubMed         Abstract available
    
    

    
    Oncologist

96. DUHORANENAYO D, Nyiraneza SE, Rugengamanzi E, Sungura R, et al
    Treatment response after chemoradiation with an external beam radiation therapy boost in cervical cancer patients in Rwanda.
    Oncologist. 2025 Oct 1:oyaf328. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Pathobiology

97. KIM M, Lee M, Kang J, Lee SJ, et al
    HPV ctDNA as a Biomarker for Monitoring Disease Progression in HPV16/18-Associated Cervical Cancer.
    Pathobiology. 2025 Sep 24:1-15. doi: 10.1159/000548452.
    PubMed         Abstract available
    
    

    
    Pathogens

98. MENG X, Yang B, Yin H, Chen J, et al
    Global Burden and Incidence Trends in Cancers Associated with Human Papillomavirus Infection: A Population-Based Systematic Study.
    Pathogens. 2025;14:880.
    PubMed         Abstract available
    
    
99. KAFASI A, Pitiriga VC, Spanakis N, Vlachos N, et al
    Evaluation of the PreTect HPV-Proofer E6/E7 mRNA Assay for the Detection of Precancerous Cervical Lesions in the Greek Female Population.
    Pathogens. 2025;14:853.
    PubMed         Abstract available
    
    

    
    PeerJ

100. SONG L, Qin K, Bai S, Wu Q, et al
     Establishment and verification of a nomogram model based on the inflammatory indicators of patients with cervical cancer for predicting the risk of their lymph node metastasis.
     PeerJ. 2025;13:e20069.
     PubMed         Abstract available
     
     

     
     Pharmaceuticals (Basel)

101. ALABDULLATIF A, Almofty S, Tanimu G, Dafalla H, et al
     Tribulus terrestris-Mediated ZnO/Ag-Halloysite Nanohybrids for Targeted Cisplatin and Carboplatin Delivery in Cervical Cancer Treatment.
     Pharmaceuticals (Basel). 2025;18:1349.
     PubMed         Abstract available
     
     

     
     Phenomics

102. GAO C, Zhou Q, Liu L, Liu H, et al
     Stratification by Mutational Landscape Reveals Differential Immune Infiltration and Predicts the Recurrence and Clinical Outcome of Cervical Cancer.
     Phenomics. 2025;5:384-403.
     PubMed         Abstract available
     
     

     
     Phys Med Biol

103. KUIPERS SC, van Tuyll van Serooskerken M, Lathouwers D, Corbeau A, et al
     Predicting lymphocyte dose and surviving fraction for VMAT and IMPT treatments with a dynamic lymphocyte flow model for locally advanced cervical cancer.
     Phys Med Biol. 2025 Sep 29. doi: 10.1088/1361-6560.
     PubMed         Abstract available
     
     

     
     PLOS Glob Public Health

104. TWABI HH, Sibande W, Mhango O, Msosa TC, et al
     Acceptability of self-sampling for high-risk HPV DNA testing for primary cervical cancer screening among women in Thyolo, Malawi: A qualitative study.
     PLOS Glob Public Health. 2025;5:e0004763.
     PubMed         Abstract available
     
     

     
     PLoS One

105. MURENZI G, Kanyabwisha F, Demarco M, Muhoza B, et al
     Determinants of cervical high-risk human papillomavirus positivity among Rwandan women living with human immunodeficiency virus.
     PLoS One. 2025;20:e0333077.
     PubMed         Abstract available
     
     
106. KAMAU SW, Jepkorir M, Kipkoech G, Lagu IJL, et al
     Antiproliferative activity of Grewia villosa ethyl acetate extract on cervical cancer HeLa cell line: Mechanistic insights through network pharmacology and functional assays approach.
     PLoS One. 2025;20:e0331649.
     PubMed         Abstract available
     
     

     
     Prev Med Rep

107. SATOH M, Sato N, Sekino M
     Behavioral economics, lifestyle, and health-related factors associated with participation in breast and cervical cancer screenings: A cross-sectional analysis of Japanese women.
     Prev Med Rep. 2025;59:103249.
     PubMed         Abstract available
     
     

     
     Radiat Prot Dosimetry

108. QIU Z, Yu X, Wang T
     Differential cardiovascular outcomes of radiotherapy in rectal, breast, and cervical cancer: insights from a SEER data analysis.
     Radiat Prot Dosimetry. 2025 Sep 29:ncaf111. doi: 10.1093.
     PubMed         Abstract available
     
     

     
     Rev Gaucha Enferm

109. MARINO JM, Silva CM, Silva UAOD, Wanderley LC, et al
     Facilitators and barriers to the Papanicolaou test on women in countryside of Amazonas.
     Rev Gaucha Enferm. 2025;46.
     PubMed         Abstract available
     
     

     
     Sci Rep

110. SHARMA M, Chourasia N, Priyanka P, Sarkar DP, et al
     Functional characterization of dysregulated LncRNAs in BRCA and CESC highlights their role in cancer prognosis.
     Sci Rep. 2025;15:34265.
     PubMed         Abstract available
     
     
111. MAQBOOL T, Hadi F, Naz S, Inamullah, et al
     Pulegone induced apoptotic and anti-proliferative potential in cervical cancer via P53, BAX and BCL2.
     Sci Rep. 2025;15:34217.
     PubMed         Abstract available
     
     
112. CHOUDHARY S, Pandey A, Singh A, Mourya A, et al
     Comparison of intravaginal and interstitial brachytherapy in cervical cancer after inadvertent hysterectomy: a retrospective study.
     Sci Rep. 2025;15:33784.
     PubMed         Abstract available
     
     
113. MASCARENHAS M, Martins M, Barroso L, Spindler L, et al
     Automated detection and classification of cervical and anal squamous cancer precursors using deep learning and multidevice colposcopy.
     Sci Rep. 2025;15:33068.
     PubMed         Abstract available
     
     

     
     Ugeskr Laeger

114. HONORE I, Bargisen M, Knudsen AS, Lyngso J, et al
     [Postcoital bleeding in premenopausal women].
     Ugeskr Laeger. 2025;187:V03250162.
     PubMed         Abstract available
     
     

     
     Vaccine

115. VAN SCHALKWYK C, Meyer-Rath G, Masuku S, Jamieson L, et al
     Cost-effectiveness of different HPV vaccination strategies for cervical cancer prevention in South Africa.
     Vaccine. 2025;64:127770.
     PubMed         Abstract available
     
     

     
     Viruses

116. CHETTA M, Rosati A, Bukvic N
     HPV as a Molecular Hacker: Computational Exploration of HPV-Driven Changes in Host Regulatory Networks.
     Viruses. 2025;17:1166.
     PubMed         Abstract available
     
     

     
     World J Clin Oncol

117. HE XY, Huang Y, Qiao CP, Ma J, et al
     Fertility anxiety partially mediates depression and recurrence fear in reproductive-age cervical cancer patients: A cross-sectional study.
     World J Clin Oncol. 2025;16:110031.
     PubMed         Abstract available
     
     

     
     Zhonghua Yi Xue Za Zhi

118. LUO S, Yin Y, Qiu L, Wang H, et al
     [Function evaluation of urinary, bowel, pelvic floor functions of patients after nerve-sparing radical hysterectomy based on CC-PRO137 scale].
     Zhonghua Yi Xue Za Zhi. 2025;105:3188-3194.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.